Pesquisas alternativas:
levels other » levels another (Expandir a Pesquisa), levels rather (Expandir a Pesquisa), levels over (Expandir a Pesquisa)
doses levels » dose levels (Expandir a Pesquisa), dose level (Expandir a Pesquisa), assess levels (Expandir a Pesquisa)
drugs does » drugs do (Expandir a Pesquisa)
does novel » does nose (Expandir a Pesquisa)
novel ther » novel ether (Expandir a Pesquisa), novel thr (Expandir a Pesquisa), novel theory (Expandir a Pesquisa)
drug doses » drug disease (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
dose like » dose live (Expandir a Pesquisa), rose like (Expandir a Pesquisa), mouse like (Expandir a Pesquisa)
like them » like thp (Expandir a Pesquisa)
levels other » levels another (Expandir a Pesquisa), levels rather (Expandir a Pesquisa), levels over (Expandir a Pesquisa)
doses levels » dose levels (Expandir a Pesquisa), dose level (Expandir a Pesquisa), assess levels (Expandir a Pesquisa)
drugs does » drugs do (Expandir a Pesquisa)
does novel » does nose (Expandir a Pesquisa)
novel ther » novel ether (Expandir a Pesquisa), novel thr (Expandir a Pesquisa), novel theory (Expandir a Pesquisa)
drug doses » drug disease (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
dose like » dose live (Expandir a Pesquisa), rose like (Expandir a Pesquisa), mouse like (Expandir a Pesquisa)
like them » like thp (Expandir a Pesquisa)
1
Por Bershad, Anya K., Kirkpatrick, Matthew G., Seiden, Jacob A., de Wit, Harriet
Publicado no J Clin Psychopharmacol (2015)
“... to investigate the effects of two other “social” drugs on plasma oxytocin levels: methamphetamine and alcohol...”Publicado no J Clin Psychopharmacol (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Smit, Johan W, Duin, Erik, Steen, Herman, Oosting, Roelof, Roggeveld, Jan, Meijer, Dirk K F
Publicado em 1998
“... agents interact with small (type 1) and bulky (type 2) cationic drugs at the level of biliary excretion...”Publicado em 1998
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Aronson, Naomi E, Koles, Nancy, Moran, Sean, Zhang, Aihong
Publicado no Open Forum Infect Dis (2018)
“... in the treatment of cutaneous leishmaniasis (CL) using dosing of 3 mg/kg/day for days 1–5, 8, 9, or days 1–5, 10...”Publicado no Open Forum Infect Dis (2018)
Obter o texto integral
Obter o texto integral
Artigo
4
“...We highlight the absence of high-level evidence from dose-ranging studies regarding the use of oral...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
“... control of overall levels of responding for a variety of commodities, including reinforcement by drug self...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Rogers, Chris A., Scott, Lauren J., Reeves, Barnaby C., Downes, Susan, Lotery, Andrew J., Dick, Andrew D., Chakravarthy, Usha
Publicado no Ophthalmol Retina (2018)
“...% CI = 1.35–9.22; P = 0.010). The hazard of an “other SSAE” (not categorized as ATE or IME) increased...”Publicado no Ophthalmol Retina (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
“.... METHODS: We describe a new dose-finding design which can be used for multiple-drug trials and can...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Chang, Pishan, Orabi, Benoit, Deranieh, Rania M., Dham, Manik, Hoeller, Oliver, Shimshoni, Jakob A., Yagen, Boris, Bialer, Meir, Greenberg, Miriam L., Walker, Matthew C., Williams, Robin S. B.
Publicado em 2012
“... known as PIP) and PtdInsP(2) (also known as PIP(2))] production caused by VPA is acute and dose...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Tomita, Takashi, Goto, Hidekazu, Yoshida, Tadashi, Tanaka, Katsuya, Sumiya, Kenji, Kohda, Yukinao
Publicado no Indian J Pharmacol (2015)
Assuntos:
“...Drug Watch...”Publicado no Indian J Pharmacol (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Jeong, Ina, Park, Jong-Sun, Cho, Young-Jae, Yoon, Ho Il, Song, Junghan, Lee, Choon-Taek, Lee, Jae-Ho
Publicado no J Korean Med Sci (2015)
“... and clinical criteria. Serum anti-TB drug levels and other clinical factors were compared between...”Publicado no J Korean Med Sci (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
“... studied the relationship between plasma level of PB and dose (2-16 mg daily) following 3 or 4 weeks...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
“.... As of 2012, the prescribed proportion of individual-level NSAID sales was 92% for low-dose aspirin, 66...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
“...1. Ouabain given by intracerebroventricular injection to mice in small doses (0·1-0·4 μg) produced...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
“... effective in preventing the infection. Diaminodiphenylsulfone was then evaluated at dose levels of 5, 25...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Sun, Yang, Liu, Chaolei, Zhang, Yuehong, Luo, Bin, She, Shouzhang, Xu, Lixin, Ruan, Xiangcai
Publicado no Med Sci Monit (2014)
Assuntos:
“...Drug Controlled Studies...”Publicado no Med Sci Monit (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
17
18
“...The administration of two different doses of indomethacin, 9 and 18 mg/kg, to two different groups...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Cooper, Jason P, Reynolds, C Patrick, Cho, Hwangeui, Kang, Min H
Publicado no Exp Biol Med (Maywood) (2017)
“... or in combination with other drugs. IMPACT STATEMENT: One of the critical components in drug development...”Publicado no Exp Biol Med (Maywood) (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
“... sometimes be induced by large doses of nicotinic acid, nicotinic acid, nicotinamide or 3-acetylpyridine...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo